Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
PhD, MD. Marek Drab Born: May 26, 1960, Cracow, Poland, Major Specialist in Research Instrumentation USI, Unit of Nanostructural Biointeractions Laboratory of Medical Microbiology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences, Wroclaw, Poland, [email protected] Academic career: 2014 - Habilitation, Medical Sciences, Cell Biology, Wroclaw Medical University 1992 - Specialization in Internal Medicine, II Degree 1991 - Ph.D., Silesian School of Medicine, Katowice, Poland, 1988 - Specialization in Internal Medicine, I degree 1985 - Physician of Human Medicine, Silesian School of Medicine, Katowice, Poland 1979-1985 - M.D., Silesian School of Medicine, Katowice, Poland Professional Experience: Scientific Metrics: Hirsch Index = 16, citations = 1902 (without self-citations), publications number = 23, impact factor = 132, Research experience record: 17 years of uninterrupted postdoctoral scientific experience in Europe and USA. Current position: October 2010 until now: Major Research Specialist in Advanced Imaging Systems and Cell Biology at the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland, with HP Freezing Cryo FIB-SEM technology Centers of scientific excellence in Europe: 2008- 2010 Senior Researcher, EU FP7 Program PEOPLE Marie-Curie for advanced researchers, INSERM Unit U1002, Necker Faculty of Medicine, University of Rene Descartes, Paris, France (webpage: http://www.necker.fr/u1002/html/people.html) and Pasteur Institute Paris, France 2004-2008 Team Leader in Dept. of Molecular Biology, Max-Planck-Institute of Infection Biology, Berlin, Germany, Since 1993 to 2004 Postdoctoral Fellow at the centers of scientific excellence in Europe and USA, i.e. Max-Planck-Institute of Cell Biology and Genetics, Dresden, Dept. of Pharmacology, Medical Faculty, Technical University of Dresden, Max-Delbrueck Center for Molecular Medicine, Berlin, Unit of Embryonic Stem Cell Research, IPK, Gatersleben, Germany, Franz-Volhard Clinic, Free University, Berlin, Dept. of Pharmacology, University of Heidelberg, all in Germany. Field of expertise: analysis of plasma membrane lipid assemblies (lipid rafts and caveolae), cell cytoskeleton, cell-to-cell junctions, ion channels, and calcium and nitric oxide signaling pathways. Biological objects of my study range from technology of the stem cells, including generating of gene knockout, in vitro differentiating tissues from totipotent and pluripotent embryonic stem cell primary cells and cell lines, whole organisms, cross tree of evolution - from mice, through sharks, to humans, and up to pathogenic bacteria like Neisseriae and Chlamydiae. Recent or Important Publications: Mammalian Host-Versus-Phage immune response determines phage fate in vivo. Hodyra-Stefaniak K, Miernikiewicz P, Drapała J, Drab M, Jończyk-Matysiak E, Lecion D, Kaźmierczak Z, Beta W, Majewska J, Harhala M, Bubak B, Kłopot A, Górski A, Dąbrowska K. Scientific Reports 2015, IF 5.578, Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors. Klein D, Schmitz T, Verhelst V, Panic A, Schenck M, Reis H, Drab M, Sak A, Herskind C, Maier P, Jendrossek V. Oncogenesis. 2015, IF 3.952 Caveolin-1 opens endothelial cell junctions by targeting catenins. Kronstein R, Seebach J, Grossklaus S, Minten C, Engelhardt B, Drab M, Liebner S, Arsenijevic Y, Taha AA, Afanasieva T, Schnittler HJ. Cardiovasc Res. 2012, IF 6.064 From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. Drab M, Haller H, Bychkov R, Erdmann B, Lindschau C, Haase H, Morano I, Luft FC, Wobus AM. FASEB J. 1997, IF: 14.629 and the Cover Page Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. Science. 2001, IF 23.329 and the dedicated Perspective article in Science by R. Parton Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. Yu J, Bergaya S, Murata T, Alp IF, Bauer MP, Lin MI, Drab M, Kurzchalia TV, Stan RV, Sessa WC. J Clin Invest. 2006 IF: 15.754 and the dedicated Commentary article in J Clin Invest. by Lisanti and Frank See also immediate comments on dr. M. Drab work in following journals: Science, 293, 2404-2405, 2001, Cell, 106, 403-411, 2001, Nature, 415, 8-10, 2002, Nature Mol Cell Biology, 2, 788, 2001, J Cell Biol 154, 904, 2001). Patents: International patent on the method of totipotent mouse embryonic stem cell in vitro differentiation into functional smooth muscle.